|
| 
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
|
 |
New variety of corn might benefit New Zealand farmers
 |
|
| A new variety of corn developed by Blue River Hybrids that is suitable for organic and biological farming systems could benefit New Zealand farmers who rely on corn seed imports as New Zealnd farming sector has a zero-toleance policy for GE crops
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
'A national energy policy is a demand driver'
|
|
| In an interview with BioSpectrum, LanzaTech CEO Dr Jennifer Holmgren, shares her views on advanced biofuels, business models adopted by the firm and policies that will enhance biofuel development |
|
|
|
|
|
CoDa Therapeutics: Revolutionizing wound healing
|
|
| New Zealand-based CoDa Therapeutics expanded its R&D presence and reached out to the US for the development of a new class of drugs for wound healing and inflammation, after discovering a revolutionizing technology for healing purposes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Fonterra announces new CEO
|
|
| Fonterra Co-operative, a global leader in dairy nutrition today announced the appointment of Mr Theo Spierings as its new CEO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
Agbiotech leaders head to New Zealand
|
|
| The world's top international agricultural biotechnology conference will be held in New Zealand in 2012, bringing unprecedented opportunities to stimulate and showcase Australasias agbiotech capability |
|
|
|
|
|
NZ brings its global game plan BIO 2011
|
|
| With a 150 year expertise in the genetic improvement of animals and plants, world-class research institutions, and a globally focused outlook, New Zealand's biotech industry is positioned as a source of innovative science, technologies and products |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
LCT receives approval to expand Diabecell NZ Trial
|
|
| Living Cell Technologies, a global company working on cell implant to treat diabetes, today reported that the Minister of Health has approved an addition to the New Zealand Phase II clinical trial of DIABECELL to include more patients. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
|
|
Acetadote launched in NZ and Australia
|
|
| Cumberland Pharmaceuticals and Phebra said that Acetadote (acetylcysteine) Injection, an injectable product used to treat acetaminophen (paracetamol) overdose, is now commercially available in the Australian market. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
|
|
Biotech spreading across all regions in New Zealand
|
|
| Twenty-one percent of biotechnology organizations are active in the Auckland region, but biotechnology activity is spread evenly across the remainder of the country, according to the Statistics New Zealand
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
